Randomised controlled trial of Jiandu granule in preventing chemoradiotherapy‐induced oral mucositis
Oral Diseases · 2024
DOI: 10.1111/odi.14745 ↗At a glance
Randomisierte kontrollierte Studie in Oral Diseases, 2024. Written by Huakang Li and 7 co-authors. Institution: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Major MEDLINE topics: Drugs, Chinese Herbal, Chemoradiotherapy, Stomatitis, Nasopharyngeal Neoplasms. Cited 2 times so far (Crossref); 30 references. Funded by: Sichuan Provincial Science and Technology Department Project.
Abstract (original language)
Objective
This clinical trial aimed to evaluate the efficacy and safety of Jiandu granule, a Chinese herbal medicine formula, for preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy. Materials and Methods A single‐centre, open‐label, randomised controlled trial was conducted, enrolling 138 patients with locally advanced nasopharyngeal carcinoma. Patients were randomly allocated to either the experimental group ( n = 69) or the control group ( n = 69). Both groups received concurrent chemoradiotherapy and standard care for oral mucositis, with the experimental group additionally receiving Jiandu granule intervention. The primary outcome was the incidence of severe oral mucositis (grade III to IV).
Results
In the full‐analysis set, severe oral mucositis occurred in 14 of 69 (20.3%) patients in the experimental group and 31 of 69 (44.9%) patients in the control group (absolute risk reduction: 24.6%; relative risk reduction: 54.8%; p = 0.002; number needed to treat: 4). Jiandu granule was associated with mild/moderate gastrointestinal reactions, with an overall incidence of 5.9%.
Conclusion
Jiandu granule reduced the incidence of severe oral mucositis in nasopharyngeal carcinoma patients during concurrent chemoradiotherapy and had an acceptable safety profile.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- The Traditional Chinese Medicine Hospital of Longquanyi, Chengdu, China.
- Sichuan Cancer Hospital, Chengdu, China.
ORCID profiles: Bing Lin
Funding
- Sichuan Provincial Science and Technology Department Project
Cite
APA
Li, H., Ke, J., Wang, X., Xu, B., Li, Q., Wu, Z., Wang, Y., & Lin, B. (2024). Randomised controlled trial of Jiandu granule in preventing chemoradiotherapy‐induced oral mucositis. Oral Diseases. https://doi.org/10.1111/odi.14745
Vancouver
Li H, Ke J, Wang X, Xu B, Li Q, Wu Z, et al. Randomised controlled trial of Jiandu granule in preventing chemoradiotherapy‐induced oral mucositis. Oral Diseases. 2024. doi:10.1111/odi.14745
BibTeX
@article{Li2024,
author = {Li, Huakang and Ke, Jianlong and Wang, Xiaoyan and Xu, Bo and Li, Qiang and Wu, Ziliang and Wang, Yue and Lin, Bing},
title = {Randomised controlled trial of Jiandu granule in preventing chemoradiotherapy‐induced oral mucositis},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14745}
}
EUVIMED